Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day
KH Fife, A Ferenczy, JM Douglas Jr… - Sexually transmitted …, 2001 - journals.lww.com
Background Medical therapy for genital warts remains suboptimal. The topical interferon and
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …
An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women
SM Garland, R Waddell, A Mindel… - … journal of STD & …, 2006 - journals.sagepub.com
Our objective was to determine the optimal duration of treatment with imiquimod for external
genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts …
genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts …
Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double‐blind, placebo‐controlled study
TA Syed, OA Ahmadpour, SA Ahmad… - The Journal of …, 1998 - Wiley Online Library
The purpose of this randomized, double‐blind, placebo‐controlled study was to determine
the clinical efficacy and tolerability of an analog of imiquimod (2%) in cream to cure genital …
the clinical efficacy and tolerability of an analog of imiquimod (2%) in cream to cure genital …
Topical imiquimod: a review of its use in genital warts
CM Perry, HM Lamb - Drugs, 1999 - Springer
Imiquimod is a topically active immunomodulatory agent that is formulated as a 5% cream
for application by the patient. It is the first agent of its class, the immune response modifiers …
for application by the patient. It is the first agent of its class, the immune response modifiers …
Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study
TA Syed, SM Hadi, ZA Qureshi, SM Ali, MS Kwah - Journal of Infection, 2000 - Elsevier
Objective: The purpose of this double-blind, placebo-controlled study was to evaluate the
safety, clinical efficacy and tole-rability of imiquimod (2%) in cream to cure external genital …
safety, clinical efficacy and tole-rability of imiquimod (2%) in cream to cure external genital …
Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations
DN Sauder, RB Skinner, TL Fox… - Sexually transmitted …, 2003 - journals.lww.com
Topical Imiquimod 5% Cream as an Effective Treatment for Ext... : Sexually Transmitted Diseases
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …
Imiquimod for the treatment of genital warts: a quantitative systematic review
RA Moore, JE Edwards, J Hopwood, D Hicks - BMC Infectious Diseases, 2001 - Springer
Objective To review published randomised controlled trials to assess the benefit and harm of
imiquimod in the treatment of external genital warts. Data sources MEDLINE (1966 …
imiquimod in the treatment of external genital warts. Data sources MEDLINE (1966 …
[引用][C] Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women
KF Trofatter Jr, A Ferenczy, KH Fife… - … of Gynecology & …, 2002 - Wiley Online Library
Patients were treated until complete resolution of baseline warts was confirmed, or for up to
16 weeks, and then entered a 4-week observation period. Patients were monitored for …
16 weeks, and then entered a 4-week observation period. Patients were monitored for …
Genital warts treatment: Beyond imiquimod
J Yuan, G Ni, T Wang, K Mounsey… - Human vaccines & …, 2018 - Taylor & Francis
Genital warts are one of the most common sexually transmitted diseases worldwide. The
disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 …
disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 …
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
KR Beutner, SK Tyring, KF Trofatter Jr… - Antimicrobial agents …, 1998 - Am Soc Microbiol
Genital human papillomavirus infection is one of the most common sexually transmitted
diseases. Imiquimod is a new agent, an immune-response modifier, that has been …
diseases. Imiquimod is a new agent, an immune-response modifier, that has been …
相关搜索
- treatment of external genital warts
- external genital warts in women
- perianal warts external genital
- genital warts topical imiquimod
- genital warts in female patients
- patient populations external genital
- imiquimod 5 cream
- effective treatment external genital
- perianal warts effective treatment
- genital warts imiquimod for the treatment
- topical imiquimod external genital
- perianal warts topical imiquimod
- effective treatment topical imiquimod
- perianal warts patient populations
- effective treatment patient populations